Mumefural Improves Recognition Memory and Alters ERK-CREB-BDNF Signaling in a Mouse Model of Chronic Cerebral Hypoperfusion
Nutrients · 2023
DOI: 10.3390/nu15143271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Min-Soo Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea. Hauptthemen laut MEDLINE: Brain Ischemia, Cognitive Dysfunction, Dementia, Vascular. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Research Council of Science and Technology (NST) of the Korean Government (MSIP), the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) through the Technology Commercialization Sup…, the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET).
Abstract (Originalsprache)
Cognitive impairment resulting from chronic cerebral hypoperfusion (CCH) is known as vascular dementia (VaD) and is associated with cerebral atrophy and cholinergic deficiencies. Mumefural (MF), a bioactive compound found in a heated fruit of Prunus mume Sieb. et Zucc, was recently found to improve cognitive impairment in a rat CCH model. However, additional evidence is necessary to validate the efficacy of MF administration for treating VaD. Therefore, we evaluated MF effects in a mouse CCH model using unilateral common carotid artery occlusion (UCCAO). Mice were subjected to UCCAO or sham surgery and orally treated with MF daily for 8 weeks. Behavioral tests were used to investigate cognitive function and locomotor activity. Changes in body and brain weights were measured, and levels of hippocampal proteins (brain-derived neurotrophic factor (BDNF), extracellular signal-regulated kinase (ERK), cyclic AMP-response element-binding protein (CREB), and acetylcholinesterase (AChE)) were assessed. Additionally, proteomic analysis was conducted to examine the alterations in protein profiles induced by MF treatment. Our study showed that MF administration significantly improved cognitive deficits. Brain atrophy was attenuated and MF treatment reversed the increase in AChE levels. Furthermore, MF significantly upregulated p-ERK/ERK, p-CREB/CREB, and BDNF levels after UCCAO. Thus, MF treatment ameliorates CCH-induced cognitive impairment by regulating ERK/CREB/BDNF signaling, suggesting that MF is a therapeutic candidate for treating CCH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
- Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon 16419, Republic of Korea.
- SONIMEDI Co., Incheon 21642, Republic of Korea.
ORCID-Profile: Min-Soo Kim
Förderung
- the National Research Council of Science and Technology (NST) of the Korean Government (MSIP)
- the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) through the Technology Commercialization Sup…
- the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET)
Zitieren
APA
Kim, M. S., Kim, B. Y., Kim, J. I., Lee, J., & Jeon, W. K. (2023). Mumefural Improves Recognition Memory and Alters ERK-CREB-BDNF Signaling in a Mouse Model of Chronic Cerebral Hypoperfusion. Nutrients. https://doi.org/10.3390/nu15143271
Vancouver
Kim MS, Kim BY, Kim JI, Lee J, Jeon WK. Mumefural Improves Recognition Memory and Alters ERK-CREB-BDNF Signaling in a Mouse Model of Chronic Cerebral Hypoperfusion. Nutrients. 2023. doi:10.3390/nu15143271
BibTeX
@article{Kim2023,
author = {Kim, Min-Soo and Kim, Bu-Yeo and Kim, Jung Im and Lee, Joungbok and Jeon, Won Kyung},
title = {Mumefural Improves Recognition Memory and Alters ERK-CREB-BDNF Signaling in a Mouse Model of Chronic Cerebral Hypoperfusion},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15143271}
}
EUVIMED